Showing 641-650 of 992 results for "".
- U.S. FDA Gives Nod to Sofwave’s SUPERB Technology for Cellulite Improvementhttps://modernaesthetics.com/news/us-fda-gives-nod-to-sofwaves-superb-technology-for-cellulite-improvement/2473342/Sofwave’s SUPERB technology is now US Food and Drug Administration (FDA)-cleared to improve the appearance of cellulite. SUPERB (Synchronous Ultrasound Parallel Beam) technology employs cooled transducers that are directly coupled to the epidermis, creating a unique
- Sientra Gives Back: Company Launches Several Breast Cancer Awareness Initiativeshttps://modernaesthetics.com/news/sientra-gives-back-company-launches-several-breast-cancer-awareness-initiatives/2473306/Sientra is launching several initiatives in honor of Breast Cancer Awareness Month. Sientra has partnered with actress and breast cancer survivor, Miranda McKeon; collaborated with the Brem Foundation to launch “Sientra Supports”; and continues to support Re
- Facial Plastic Surgeons Give Back: AAFPRS Members Plan September Mission to Ukrainehttps://modernaesthetics.com/news/facial-plastic-surgeons-give-back-aafprs-members-plan-september-mission-to-ukraine/2473284/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) FACE TO FACE program will soon travel to the Ukraine on a medical mission to assist those with facial injuries suffered because of the Russia/Ukraine conflict. The nine-d
- Study: Sick Patients Get Cosmetic Surgery to Look Healthierhttps://modernaesthetics.com/news/study-sick-patients-get-cosmetic-surgery-to-look-healthier/2473216/Patients dealing with serious illnesses may want cosmetic procedures to make them look healthier, reports a small new Northwestern Medicine study. The patients believe cosmetic surgery may help them feel better in social situations with their friends, family or when they’re at work. &n
- Jeune Aesthetics Shares Positive Clinical Phase 1 Data for Investigational Gene-based Treatment to Address the Underlying Biology of Aging Skinhttps://modernaesthetics.com/news/jeune-aesthetics-shares-positive-clinical-phase-1-data-for-investigational-gene-based-treatment-to-address-the-underlying-biology-of-aging-skin/2473210/Jeune Aesthetics, Inc., a wholly-owned subsidiary of Krystal Biotech, Inc. shared positive proof-of-concept efficacy data from Cohort 2 of its PEARL-1 study of KB301, Jeune Aesthetics’ lead candidate for the treatment of aesthetic skin conditions. “We are pleased to see
- Geneo Partners with Country Singer Jessie James Deckerhttps://modernaesthetics.com/news/geneo-partners-with-country-singer-jessie-james-decker/2473124/
- Price Transparency Webinar Goes Live on Thursday from BuildMyBod Healthhttps://modernaesthetics.com/news/price-transparency-webinar-goes-live-on-thursday-from-buildmybod-health/2473119/A webinar planned this week with Jonathan Kaplan, MD, founder of BuildMyBod Health, will help aesthetic physicians understand the role of automated cosmetic and insurance-based price listing on a practice website. As part of the educational program scheduled June 24 at 3pm EDT, attendee
- Dove Gives Back with the Dove Forest Restoration Projecthttps://modernaesthetics.com/news/dove-gives-back-with-the-dove-forest-restoration-project/2473113/Dove is launching the Dove Forest Restoration Project, one of the biggest protection and restoration efforts from any beauty brand to-date. The project is designed to protect and restore forests, protect the habitats of endangered species, and improve the livelihoods of 16,000 peo
- Sofwave Medical Goes Public on the Tel Aviv Stock Exchange, Raises $50Mhttps://modernaesthetics.com/news/sofwave-medical-goes-public-on-the-tel-aviv-stock-exchange-raises-50m/2473109/Sofwave Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE) and raised $50 million at a pre-money valuation of ~$200 million. The IPO was led by Barak Capital Underwriters. The company has developed Synchronous Ul
- Forget Injectables, Patients with Benign Skin Lesions Want Them Gonehttps://modernaesthetics.com/news/forget-injectables-patients-with-benign-skin-lesions-prioritize/2473097/A majority of patients with unwanted benign lesions are interested in a new procedure to clear these lesions, according to a new survey by Pulse Biosciences that was presented at the American Academy of Dermatology (AAD) Virtual Annual Meeting. A diverse sample of 405 aesthetic patients